Acute Leukemias - Republican Scientific Medical Library

More documents

Recommendations

Info

128 Chapter 8 · Diagnosis of Acute Lymphoblastic Leukemia 15. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci 99:15524–15529 16. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci 101:2999–3004 17. Carney LA, Kinney JS, Higgins RR, Freeman AI, Hecht BK, Woods GM (1992) X;6 translocation in a child with congenital acute lymphocytic leukemia. Cancer 69:799–803 18. Cave H, Cacheux V, Raynaud S, Brunie G, Bakkus M, Cochaux P, Preudhomme C, Lai JL, Vilmer E, Grandchamp B (1997) ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia. Leukemia 11:1459–1464 19. Cave H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A, Malet M, Boutard P, Benoit Y, Mauvieux L, et al. (2004) Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: Results of EORTC studies 58881 and 58951. Blood 103:442–450 20. Codrington R, O’Connor HE, Jalali GR, Carrara P, Papaioannou M, Hart SM, Hoffbrand AV, Potter M, Prentice HG, Harrison CJ, et al. (2000) Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: Incidence, alternative spliced forms and minimal residual disease value. Br J Haematol 111:1071–1079 21. Cortes JE, Kantarjian H, Freireich EJ (1996) Acute lymphocytic leukemia: A comprehensive review with emphasis on biology and therapy. Cancer Treat Res 84:291–323 22. Chung CY, Kantarjian H, Haidar M, Starostik P, Manshouri T, Gidel C, Freireich E, Keating M, Albitar M (2000) Deletions in the 13q14 locus in adult lymphoblastic leukemia: Rate of incidence and relevance. Cancer 88:1359–1364 23. Daheron L, Brizard F, Millot F, Cividin M, Lacotte L, Guilhot F, Brizard A (2003) E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype. Hematol J 3:153–156 24. Evens AM, Gordon LI (2002) Burkitt’s and Burkitt-like lymphoma. Curr Treat Options Oncol 3:291–305 25. Faber J, Kantarjian H, Roberts MW, Keating M, Freireich E, Albitar M (2000) Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia. Arch Pathol Lab Med 124:92–97 26. Faderl S, Albitar M (2000) Insights into the biologic and molecular abnormalities in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am 14:1267–1288 27. Faderl S, Jeha S, Kantarjian HM (2003) The biology and therapy of adult acute lymphoblastic leukemia. Cancer 98:1337–1354 28. Faderl S, Kantarjian HM, Manshouri T, Chan CY, Pierce S, Hays KJ, Cortes J, Thomas D, Estrov Z, Albitar M (1999) The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia. Clin Cancer Res 5:1855–1861 29. Ferrando AA, Look AT (2003) Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol 40:274–280 30. Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH, Rowe JM, Caligiuri MA, Bloomfield CD, Look AT (2004) Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet 363 (9408):535–536 31. Fleming DR, Doukas MA, Jennings DC, Davey DD (2000) Diagnostic and clinical implications of lineage fidelity in acute leukemia patients undergoing allogeneic stem cell transplantation. Leuk Lymphoma 2000 36:309–313 32. Foa R, Vitale A, Mancini M, Cuneo A, Mecucci C, Elia L, Lombardo R, Saglio G, Torelli G, Annino L, et al. (2003) E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: Biological and clinical features. Br J Haematol 120:484–487 33. Gauwerky CE, Croce CM (1993) Chromosomal translocations in leukaemia. Semin Cancer Biol 4:333–340 34. Gotoh A, Broxmeyer HE (1997) The function of BCR/ABL and related proto-oncogenes. Curr Opin Hematol 4:3–11 35. Haidar MA, Kantarjian H, Manshouri T, Chang CY, O’Brien S, Freireich E, Keating M, Albitar M (2000) ATM gene deletion in patients with adult acute lymphoblastic leukemia. Cancer 88:1057–1062 36. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (2000) The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting7Airlie House, Virginia, November, 1997. Hematol J 1:53–66 37. Hay CR, Barnett D, James V, Woodcock BW, Brown MJ, Lawrence AC (1987) Granular common acute lymphoblastic leukaemia in adults: A morphological study. Eur J Haematol 39:299–305 38. Hayashi Y, Raimondi SC, Look AT, Behm FG, Kitchingman GR, Pui CH, Rivera GK, Williams DL (1990) Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood 76:1626–1630 39. Hecht JL, Aster JC (2000) Molecular biology of Burkitt’s lymphoma. J Clin Oncol 18:3707–3721 40. Hilden JM, Kersey JH (1994) The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4;11) acute leukemia: Molecular and clinical studies. Leuk Lymphoma 14:189–195 41. Hsu HL, Wadman I, Tsan JT, Baer R (1994) Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc Natl Acad Sci 91:5947–5951 42. Invernizzi R, Rosanda C, Basso G, Conter V, di Cataldo A, Fenu S, Forni M, Frappampina V, Granchi D, Locatelli F, et al (1992) Granular acute lymphoblastic leukemia in children. “AIEOP Cooperative Group for Cytology of Acute Leukemias”. Haematologica 77:30–34 43. Jalali GR, Martineau M, Ford AM, Greaves M, Stevens RF, Harrison CJ (2003) A unique variant of ETV6/AML1 fusion in a child with acute lymphoblastic leukemia. Leukemia 17:993–995 44. Kanerva J, Saarinen-Pihkala UM, Riikonen P, Makipernaa A, Mottonen M, Salmi TT (1999) Reemphasis on lymphoblast L2 morphology as a poor prognostic factor in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 33:388–394 45. Kebriaei P, Anastasi J, Larson RA (2002) Acute lymphoblastic leukaemia: Diagnosis and classification. Best Pract Res Clin Haematol 15:597–621 46. Kees UR, Heerema NA, Kumar R, Watt PM, Baker DL, La MK, Uckun FM, Sather HN (2003) Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: A study from the Children’s Cancer Group (CCG). Leukemia 17:887–893
a References 129 47. Kita K, Shirakawa S, Kamada N (1994) Cellular characteristics of acute myeloblastic leukemia associated with t(8;21)(q22;q22). The Japanese Cooperative Group of Leukemia/Lymphoma. Leuk Lymphoma 13:229–234 48. Kohlmann A, Schoch C, Schnittger S, Dugas M, Hiddemann W, Kern W, Haferlach T (2004) Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. Leukemia 18:63–71 49. Legrand O, Perrot JY, Simonin G, Baudard M, Cadiou M, Blanc C, Ramond S, Viguie F, Marie JP, Zittoun R (1998) Adult biphenotypic acute leukaemia: An entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression. Br J Haematol 100:147–155 50. Liu Y, Hermanson M, Grander D, Merup M, Wu X, Heyman M, Rasool O, Juliusson G, Gahrton G, Detlofsson R, et al. (1995) 13q deletions in lymphoid malignancies. Blood 86:1911–1915 51. Look AT (1997) E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastic leukemia. Curr Top Microbiol Immunol 220:45–53 52. Macon WR, Williams ME, Greer JP, Hammer RD, Glick AD, Collins RD, Cousar JB (1996) Natural killer-like T-cell lymphomas: Aggressive lymphomas of T-large granular lymphocytes. Blood 87:1474– 1483 53. Maitra A, McKenna RW, Weinberg AG, Schneider NR, Kroft SH (2001) Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol 115:868–875 54. Martineau M, Berger R, Lillington DM, Moorman AV, Secker-Walker LM (1998) The t(6;11)(q27;q23) translocation in acute leukemia: A laboratory and clinical study of 30 cases. EU Concerted Action 11q23 Workshop participants. Leukemia 12:788–791 55. Matloub YH, Brunning RD, Arthur DC, Ramsay NK (1993) Severe aplastic anemia preceding acute lymphoblastic leukemia. Cancer 71:264–268 56. Miller DR, Leikin S, Albo V, Sather H, Hammond D (1981) Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL). Br J Haematol 48:199–206 57. Moos PJ, Raetz EA, Carlson MA, Szabo A, Smith FE, Willman C, Wei Q, Hunger SP, Carroll WL (2002) Identification of gene expression profiles that segregate patients with childhood leukemia. Clin Cancer Res 8:3118–3130 58. Mrozek K, Heerema NA, Bloomfield CD (2004) Cytogenetics in acute leukemia. Blood Rev 18:115–136 59. Oguchi K, Takagi M, Tsuchida R, Taya Y, Ito E, Isoyama K, Ishii E, Zannini L, Delia D, Mizutani S (2003) Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement. Blood 101:3622–3627 60. Okuda T, Shurtleff SA, Valentine MB, Raimondi SC, Head DR, Behm F, Curcio-Brint AM, Liu Q, Pui CH, Sherr CJ, et al. (1995) Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 85:2321–2330 61. Paietta E, Neuberg D, Richards S, Bennett JM, Han L, Racevskis J, Dewald G, Rowe JM, Wiernik PH; Eastern Cooperative Oncology Group (2001) Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity. Am J Hematol 66:189–196 62. Peffault de Latour R, Legrand O, Moreau D, Perrot JY, Blanc CM, Chaoui D, Casadevall N, Marie JP (2003) Comparison of flow cyto- metry and enzyme cytochemistry for the detection of myeloperoxydase in acute myeloid leukaemia: Interests of a new positivity threshold. Br J Haematol 122:211–216 63. Pongers-Willemse MJ, Seriu T, Stolz F, d’Aniello E, Gameiro P, Pisa P, Gonzalez M, Bartram CR, Panzer-Grumayer ER, Biondi A, et al. (1999) Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia. Leukemia 13:110–118 64. Potter VP, Sorell M, Baglivo JA, Sather H, Miller DR (1984) Prognostic significance of vacuoles in L1 lymphoblasts in childhood acute lymphoblastic leukaemia: A report from Children’s Cancer Study Group. Br J Haematol 56:215–222 65. Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350:1535–1548 66. Quesnel B, Preudhomme C, Fenaux P (1996) p16ink4a gene and hematological malignancies. Leuk Lymphoma 22:11–24 67. Raimondi SC, Zhou Y, Mathew S, Shurtleff SA, Sandlund JT, Rivera GK, Behm FG, Pui CH (2003) Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia. Cancer 98:2715–2722 68. Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK, Liu HC, Mahfouz R, Raimondi SC, Lenny N, et al. (2003) Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102:2951–2959 69. Rubnitz JE, Behm FG, Downing JR (1996) 11q23 rearrangements in acute leukemia. Leukemia 10:74–82 70. Salvati PD, Watt PM, Thomas WR, Kees UR (1999) Molecular characterization of a complex chromosomal translocation breakpoint t(10;14) including the HOX11 oncogene locus. Leukemia 13:975– 979 71. Schumacher HR (1998) Acute leukemia: Difficult, controversial, and automated analyzers. Williams & Wilkins, Baltimore 72. Shimamoto Y, Matsuzaki M, Yamaguchi M (1992) Vacuolated Burkitt-like cells in adult T-cell leukaemia/lymphoma. Clin Lab Haematol 14:155–157 73. Slater RM, von Drunen E, Kroes WG, Weghuis DO, van den Berg E, Smit EM, van der Does-van den Berg A, van Wering E, Hahlen K, Carroll AJ, et al. (2001) t(7;12)(q36;p13) and t(7;12)(q32;p13)-translocations involving ETV6 in children 18 months of age or younger with myeloid disorders. Leukemia 15:915–920 74. Takeuchi S, Koike M, Seriu T, Bartram CR, Schrappe M, Reiter A, Park S, Taub HE, Kubonishi I, Miyoshi I, et al. (1998) Frequent loss of heterozygosity on the long arm of chromosome 6: Identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Res 58:2618–2623 75. Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, Jaeger U, Lechner K, Schneider B, Fonatsch C, Schwarzinger I (2002) The immunophenotype of 325 adult acute leukemias: Relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol 117:380–389 76. Uckun FM, Sensel MG, Sather HN, Gaynon PS, Arthur DC, Lange BJ, Steinherz PG, Kraft P, Hutchinson R, Nachman JB, et al. (1998) Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies:
Page 1 and 2:
E.H. Estey · S.H. Faderl · H. M.
Page 3 and 4:
E. H. Estey Department of Leukemia
Page 5 and 6:
VI Table of Contents 14 Philadelphi
Page 7 and 8:
VIII Contributors S. H. Faderl Depa
Page 9 and 10:
X Contributors D. Wartenberg Depart
Page 11 and 12:
Therapy of AML Elihu Estey Contents
Page 13 and 14:
a 1.2 · Standard Therapy 3 Table 1
Page 15 and 16:
a 1.2 · Standard Therapy 5 Table 1
Page 17 and 18:
a 1.2 · Standard Therapy 7 tween G
Page 19 and 20:
a 1.2 · Standard Therapy 9 Fig. 1.
Page 21 and 22:
a 1.2 · Standard Therapy 11 of tre
Page 23 and 24:
a 1.2 · Standard Therapy 13 Table
Page 25 and 26:
a 1.2 · Standard Therapy 15 permit
Page 27 and 28:
a References 17 19. Care RS, Valk P
Page 29 and 30:
a References 19 6-thioguanine in th
Page 31 and 32:
Acute Myeloid Leukemia: Epidemiolog
Page 33 and 34:
a 3.1 · Epidemiology 49 3.1.4 Gend
Page 35 and 36:
a 3.2 · Etiology 51 part of the in
Page 37 and 38:
a 3.2 · Etiology 53 for the develo
Page 39 and 40:
a References 55 38. Crane MM, Stom
Page 41 and 42:
Relapsed and Refractory Acute Myelo
Page 43 and 44:
a 4.2 · Prognostic Factors in Pati
Page 45 and 46:
a 4.3 · Treatment of Relapsed and
Page 47 and 48:
a 4.4 · Hematopoietic Stem Cell Tr
Page 49 and 50:
a 4.6 · Gemtuzumab Ozogamicin 65 T
Page 51 and 52: a 4.7 · Relapsed and Refractory Ac
Page 53 and 54: a 4.7 · Relapsed and Refractory Ac
Page 55 and 56: a References 71 The ability of immu
Page 57 and 58: a References 73 39. Vogler WR, McCa
Page 59 and 60: a References 75 95. Sievers EL, Lar
Page 61 and 62: Part II - Acute Lymphoblastic Leuke
Page 63 and 64: 78 Chapter 5 · Acute Lymphoblastic
Page 79 and 80: Molecular Biology and Genetics Meir
Page 81 and 82: a 6.3 · Structural Aberrations 97
Page 83 and 84: a 6.3 · Structural Aberrations 99
Page 85 and 86: a 6.5 · Molecular Aberrations 101
Page 87 and 88: a References 103 clear that homozyg
Page 89 and 90: a References 105 53. Chim CS, Tam C
Page 91 and 92: a References 107 122. Lennard L, Li
Page 93 and 94: Diagnosis of Acute Lymphoblastic Le
Page 95 and 96: a 8.3 · Cytochemistry and Immunoph
Page 97 and 98: a 8.5 · Cytogenetic and Molecular
Page 99 and 100: a 8.5 · Cytogenetic and Molecular
Page 101: a References 127 including the reti
Page 105 and 106: Acute Lymphoblastic Leukemia: Clini
Page 107 and 108: a 7.3 · Diagnosis 111 or neoplasti
Page 109 and 110: a 7.3 · Diagnosis 113 Fig. 7.2. Hi
Page 111 and 112: a 7.3 · Diagnosis 115 The vast maj
Page 113 and 114: a References 117 dren: Biologic bas
Page 115 and 116: General Approach to the Therapy of
Page 117 and 118: a 9.3 · New Agents 133 dose methot
Page 119 and 120: a References 135 4. Gökbuget N, Ho
Page 121 and 122: 138 Chapter 10 · Recent Clinical T
Page 129 and 130: 146 Chapter 11 · Conventional Ther
Page 143 and 144: ALL Therapy: Review of the MD Ander
Page 145 and 146: a 12.2 · The Hyper-CVAD Regimen in
Page 147 and 148: a 12.3 · Subset-Specific Approache
Page 149 and 150: Treatment of Adult ALL According to
Page 151 and 152: a 13.2 · Therapy for Younger (15-6
Page 153 and 154:
a 13.3 · Therapy of Ph/BCR-ABL-Pos
Page 155 and 156:
a 13.5 · Prognostic Factors 173 13
Page 157 and 158:
a References 175 Only patients with
Page 159 and 160:
Philadelphia Chromosome-Positive Ac
Page 161 and 162:
a 14.2 · Molecular Biology of the
Page 163 and 164:
a 14.3 · Treatment of Ph+ ALL 181
Page 165 and 166:
a 14.4 · Hematopoietic Stem Cell T
Page 167 and 168:
a References 185 2. Kurzrock R, Sht
Page 169 and 170:
a References 187 56. Mori T, Manabe
Page 171 and 172:
a References 189 acute lymphoblasti
Page 173 and 174:
192 Chapter 15 · Burkitt’s Acute
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
204 Chapter 16 · Treatment of Lymp
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
216 Chapter 17 · The Role of Allog
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
230 Chapter 18 · The Role of Autol
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
238 Chapter 19 · Novel Therapies i
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
248 Chapter 20 · Minimal Residual
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
264 Chapter 21 · Central Nervous S
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
276 Chapter 22 · Relapsed Acute Ly
Page 259 and 260:
278 Chapter 22 · Relapsed Acute Ly
Page 261 and 262:
Emergencies in Acute Lymphoblastic
Page 263 and 264:
a 23.5 · Hyperleukocytosis 283 LA
Page 265 and 266:
a 23.9 · Neurological Complication
Page 267 and 268:
a References 287 29. Hingorani AD,
Page 269 and 270:
Subject Index A aberrant methylatio
Page 271 and 272:
a Subject Index 291 CREB, see enhan
Page 273 and 274:
a Subject Index 293 MUD, see matche
show all

Acute Leukemias - Republican Scientific Medical Library

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?